Table 2.
Consequences of anticancer treatment on the sperm count in HL patients.
Anticancer Treatment | Pre-Treatment | Post-Treatment * | Reference | ||
---|---|---|---|---|---|
Normospermia (% of Patients) | Normospermia (% of Patients) | Oligospermia (% of Patients) | Azoospermia (% of Patients) | ||
MOPP | 100 | 28 | 24 | 48 | Da Cunha et al., 1984 [63] |
MOPP | 100 | 3 | 0 | 97 | Viviani et al., 1985 [15] |
MOPP | 84 | 0 | 62 | 38 | Meistrich et al., 1997 [66] |
MOPP | 100 | 20 | 35 | 45 | Sánchez et al., 2008 [70] |
MOPP | 100 | NA | NA | 75 | Bujan et al., 2014 [67] |
ABVD | 100 | 46 | 21 | 33 | Viviani et al., 1985 [15] |
ABVD | 100 | 80 | 15 | 5 | Sánchez et al., 2008 [70] |
ABVD | 100 | 100 | 0 | 0 | Bujan et al., 2014 [67] |
NOVP | 100 | 50 | 50 | 0 | Frias et al., 2003 [71] |
NA = Not available. * The post-treatment time used in the studies was variable, from one month to 23 years.